India’s diabetes burden is at a critical juncture, with national prevalence estimated at 11.4%, according to a landmark nationwide survey by the Madras Diabetes Research Foundation (MDRF) and Indian Council of Medical Research (ICMR), published in The Lancet Diabetes & Endocrinology. This translates to 101 million people living with diabetes and 136 million with prediabetes in India as of 2021. The survey, which assessed over 113,000 individuals across 31 states and Union Territories, highlights a 50% increase in diabetes prevalence since 2017 (from 7.5% to 11.4%), signaling a rapidly accelerating epidemic.
Despite this alarming rise, awareness, treatment, and control remain deeply inadequate. The National Family Health Survey (NFHS-5, 2019–2021) reveals that only 27.5% of people with diabetes are aware of their condition, 21.5% are receiving treatment, and a mere 7% have their diabetes under control. This stark gap underscores a major public health challenge: a large proportion of the population is unaware of their risk or diagnosis, leading to delayed interventions and higher complications.
Socioeconomic disparities further exacerbate the crisis. The survey found significant inequalities in diabetes awareness, treatment, and control across wealth quintiles, education levels, and urban-rural divides. While urban areas report higher rates of diabetes and related conditions like hypertension and obesity, rural regions are expected to see a sharp rise in the coming years. States like Goa (26.4%) and Punjab (51.8% hypertension) show the highest burdens, indicating regional variations that demand targeted policy responses.
Key risk factors driving India’s diabetes surge include genetic predisposition, “thin-fat” body composition (high visceral fat despite normal BMI), sedentary lifestyles, urban stress, and diets high in refined carbohydrates—such as white rice, maida, and sugary drinks. Experts stress that early screening, portion control, regular physical activity, and preventive healthcare are essential to curb the epidemic. The data from this survey is not just a warning—it is a call for urgent, evidence-based state-specific policies and nationwide public health campaigns to prevent a future of preventable complications like blindness, kidney failure, heart attacks, and amputations.
